A Study for Newly Diagnosed Patients with Retinoblastoma in India
Not Applicable
Completed
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2020/09/027846
- Lead Sponsor
- Cankids Kidscan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 1120
Inclusion Criteria
Inclusion Criteria
1. Age < 18 yrs
2. All new patients must be staged and should be enrolled within 4 weeks of diagnosis and
staging. If staged previously, they must be formally reassessed.
3. Informed consent should be taken from all parents for enrolling the subjects in this
study.
Exclusion Criteria
Exclusion Criteria
Patients who have relapsed after completion of frontline treatment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall Survival <br/ ><br>Event Free SurvivalTimepoint: 5 Years from date of Diagnosis of Disease / Recruitment date <br/ ><br>(last patient is estimated to be recruited from 3 years of start of recruitment) <br/ ><br>1- year and subsequent year survival rate will also be analyzed and presented
- Secondary Outcome Measures
Name Time Method Factors leading to delayed treatment <br/ ><br>visual outcomes for patients with ocular salvageTimepoint: 1 year